MFC Forum 2013
Schedule & Location
The meeting and dinner will both take place at the Hilton, O'Hare, accesible via the terminals at O'Hare International Airport.
November 11 - Dinner at Hilton O'Hare, Paris AB Room. Drinks start at 6pm with dinner at 7pm. For those participating in the MPNRF video, contact Michelle regarding your target arrival time at 312-683-7243 or firstname.lastname@example.org
November 12 - Click here for the schedule & agenda. The meeting will take place from 9:00 am - 3:00 pm in the Chicago Room of the Hilton O'Hare. Breakfast will be served at 8:00 am. Lunch will be provided.
Sleeping rooms have been arranged through the Hilton O’Hare November 11-12. If you need additional accommodations please contact Michelle at email@example.com.
Please make your own travel arrangements. The Foundation will reimburse expenses upon receipt of documentation, which can be submitted via fax or email.
The overall agenda for the meeting will include:
- A keynote presentation on fibrosis is the current state of stem cell research, especially as related to myelofibrosis and the bone marrow environment.
- Presentations from 2012 MF Challenge grantees, highlighting work completed as part of their MF Challenge grant. Each presentation will be followed by an opportunity for questions and answers.
- A moderated discussion with all participants that will address the following issues:
- What are the opportunities for follow-up research related to the morning’s presentations?
- Specifically where are the opportunities for collaborations between industry and academia in the context of MF research?
- What are the unmet needs that should guide future grant programs for the Foundation?
- What else can the Foundation do to promote progress in MF research?
About the 2013 MFC Forum
In 2012 the MPN Research Foundation, with the Leukemia & Lymphoma Society (LLS) as partner, instituted the MF Challenge, a grant program focused on understanding the causes of bone marrow fibrosis in MF patients and identifying ways to halt and reverse it. It is our hope that by stimulating new ideas in this area in parallel with ongoing development of JAK2 inhibitors, that a coordinated approach for treating MF patients can be developed that will truly improve the prognoses for these patients.
As part of that program, we would like to invite you to a special one-day event on Tuesday, November 12, 2013. This event, which we are calling the 2013 MFC Forum, is designed to build on the current state of MF research and to further accelerate the development of MF treatments.
The objective of the 2013 MFC Forum is to showcase the work of MF Challenge grantees, identify unmet needs in MF research, and promote an exchange of ideas between industry partners and academic researchers. We are inviting our grantees, (from both 2012 and 2013), other academic experts, and representatives from biotech and pharmaceutical companies (maximum of 2 per company) with an investment in the future of MF research. Participation in the meeting will be limited to roughly 35 to encourage conversation, and the discussion will be moderated to ensure efficient use of time.